BD Lee Laboratories

BD Lee Labs maintains special expertise in providing animal model inflammation research products: PGPS (Streptococcal Cell Wall), Complete and Incomplete Freund's Adjuvant, and M. tuberculosis H37RA. PGPS is easy to use and provides a very short animal model response time.

BD Lee is an FDA regulated facility which follows cGMP and ISO 2001 manufacturing guidelines.

Activity:

- Manufacturing
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- Bio
- Diagnostics
- Pharmaceuticals / Therapeutics
- Reagents

Therapeutic targets:

- Arthritis / Rheumato
- Asthma
- Cardiovascular
- Central nervous system
- Gastrointestinal
- Pain

Markets Covered

a. HeadQuarter: United States of America

b. Continent(s) active: North America , Europe , Asia

c. Countries active: US, UK, CA, DE, FR, IT, CHINA, JP

Corporate data:

Number of Employees: 20000

Turnover:

Amount:	Year:	Currency:
4,500,000,000	2002	US Dollar

Year founded: 1886

Stock options:

	Symbol	Exchange
1	BDX